IDRx’s lead candidate IDRX-42 is being investigated in a Phase I/IIb trial in patients with advanced gastrointestinal stromal tumours.

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

This means families must pay the full list price ... The pulmonologists said GSK’s decision to discontinue its brand-name inhaler has made it harder for some children to access medication ...

Save the Children and GSK have partnered together in the U.S since 2015, providing immediate emergency relief to children and families when disaster strikes and working to build safer and more ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn ... It has not announced any major settlements. A drug under the name of Zantac 360, which contains no ranitidine, is still being ...